In this study focusing on visfatin’s role on BBB integrity and the effects of small cell lung carcinoma metastasis, Liu et al. found that visfatin-mediated upregulation of CCL2 may contribute to the metastasis of SCLC to the brain. The gene discussed is CCL2; the disease is small cell lung carcinoma.